kw.\*:("advanced penile cancer")
Results 1 to 1 of 1
Selection :
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)THEODORE, C; SKONECZNA, I; BODROGI, I et al.Annals of oncology. 2008, Vol 19, Num 7, pp 1304-1307, issn 0923-7534, 4 p.Article
